Internal Medicine, Medical Oncology · Corpus Christi, TX
NPI
1659569507
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
7121 S. Padre Island Dr, Suite 102-101,119
Corpus Christi, TX, 78412
Phone (361) 696-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$607K
36,336 services
Medicare patients, 2024
177
Average age 74
Drug cost, 2024
$5.3M
1,753 prescriptions
Company payments, 2025
$3,882
From 47 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julio A Peguero was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,100 times for 11 patients. In total Julio A Peguero billed 36,336 services in 96 codes, and Medicare paid $607K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,100 | 11 | $0.10 | $114 |
| 85025 Blood Count | Office | 355 | 152 | $7.61 | $2,702 |
| 99214 Office E&M - Established | Office | 248 | 116 | $97.95 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 161 | 92 | $12.95 | $2,086 |
| 99213 Office E&M - Established | Office | 104 | 78 | $59.74 | $6,212 |
| 36415 Venipuncture Blood Collection | Office | 41 | 21 | $8.65 | $355 |
| 96372 Injection Administration | Office | 40 | 14 | $10.82 | $433 |
| 78815 PET- Oncology | Office | 30 | 25 | $1,260.20 | $38K |
| A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 29 | 24 | $104.53 | $3,031 |
| 96365 Intravenous Infusion, Hydration | Office | 28 | 11 | $44.01 | $1,232 |
| 99204 Office E&M - New | Office | 24 | 24 | $117.67 | $2,824 |
| 99205 Office E&M - New | Office | 17 | 17 | $175.91 | $2,990 |
| 82565 Clinical Chemistry | Office | 11 | 11 | $5.02 | $55.22 |
By year: 2022 $579K for 57,612 services; 2023 $513K for 29,433 services; 2024 $607K for 36,336 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 355 | 152 | $7.61 | $2,702 |
| 36415 Venipuncture Blood Collection | 41 | 21 | $8.65 | $355 |
| 82565 Clinical Chemistry | 11 | 11 | $5.02 | $55.22 |
Medicare prescription drug claims, 2024
In 2024, the drug Julio A Peguero prescribed most often to Medicare patients was Exemestane, with 176 prescriptions and refills. In total Julio A Peguero wrote 1,753 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Exemestane Generic | 176 | 484 | 73 | $33K |
| Prednisone Generic | 75 | 103 | 25 | $320 |
| Dexamethasone Generic | 62 | 75 | 41 | $1,469 |
| Erleada Apalutamide | 60 | 60 | 12 | $810K |
| Granisetron Hcl Generic | 57 | 57 | 46 | $17K |
| Eliquis Apixaban | 53 | 92 | 19 | $54K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 45 | 45 | 38 | $471 |
| Letrozole Generic | 44 | 90 | 13 | $863 |
| Ondansetron Odt Ondansetron | 44 | 44 | 35 | $925 |
| Famciclovir Generic | 43 | 73 | 18 | $3,093 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 42 | 42 | 26 | $1,207 |
| Hydroxyurea Generic | 40 | 103 | 17 | $1,285 |
| Loperamide Loperamide Hcl | 38 | 38 | 27 | $390 |
| Abiraterone Acetate Generic | 34 | 34 | Under 11 | $96K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 34 | 49 | 15 | $125 |
Brand drugs: - claims; generic drugs: 1,283 claims; opioid claims: 68.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julio A Peguero $3,882 ($3,882 in general payments such as food, travel and fees) from 47 companies. The largest payer was Telix Pharmaceuticals with $570.
| Company | Payments | Amount |
|---|---|---|
| Telix Pharmaceuticals TLX | 6 | $570 |
| Pfizer Inc. PFE | 17 | $422 |
| Abbvie Inc. ABBV | 6 | $305 |
| GlaxoSmithKline, LLC. GSK | 11 | $272 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $232 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $195 |
| Tempus AI, Inc TEM | 10 | $174 |
| Janssen Biotech, Inc. JNJ | 7 | $147 |
| Genzyme Corporation SNY | 4 | $140 |
| Eisai Inc. 4523.T | 6 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.